Functional analysis of miR-23−27−24 cluster miRNAs in skeletal muscle plasticity

1 Smerdu, V., Karsch-Mizrachi, I., Campione, M., Leinwand, L. & Schiaffino, S. Type IIx myosin heavy chain transcripts are expressed in type IIb fibers of human skeletal muscle. Am J Physiol 267, C1723-1728, doi:10.1152/ajpcell.1994.267.6.C1723 (1994).

2 Maughan, R. J., Watson, J. S. & Weir, J. Relationships between Muscle Strength and Muscle Cross-Sectional Area in Male Sprinters and Endurance Runners. Eur J Appl Physiol Occup Physiol 50, 309-318 (1983).

3 Schiaffino, S. & Reggiani, C. Fiber types in mammalian skeletal muscles. Physiol Rev 91, 1447-1531, doi:10.1152/physrev.00031.2010 (2011).

4 Ausoni, S., Gorza, L., Schiaffino, S. G., K. & Lømo, T. Expression of myosin heavy chain isoforms in stimulated fast and slow rat muscles. J Neurosci 10, 153-160 (1990).

5 Sandona, D. et al. Adaptation of mouse skeletal muscle to long-term microgravity in the MDS mission. PLoS One 7, e33232, doi:10.1371/journal.pone.0033232 (2012).

6 Prince, F. P., Hikida, R. S. H., F. C., Staron, R. S. & Allen, W. H. A morphometric analysis of human muscle fibers with relation to fiber types and adaptations to exercise. J Neurol Sci 49, 165-179 (1981).

7 Eddinger, T. J. & Moss, R. L. Mechanical properties of skinned single fibers of identified types from rat diaphragm. Am J Physiol 253, C210-218, doi:10.1152/ajpcell.1987.253.2.C210 (1987).

8 Musarò, A. et al. Localized Igf-1 transgene expression sustains hypertrophy and regeneration in senescent skeletal muscle. Nat Genet 27, 195-200, doi:10.1038/84839 (2001).

9 Handschin, C. S., B.M. The role of exercise and PGC1α in inflammation and chronic disease. Nature 454, 463-469 (2008).

10 Wu, Z. et al. Mechanisms Controlling Mitochondrial Biogenesis and Respiration through the Thermogenic Coactivator PGC-1. Cell 98, 115-124, doi:10.1016/s0092-8674(00)80611-x (1999).

11 St-Pierre, J. et al. Bioenergetic analysis of peroxisome proliferator-activated receptor gamma coactivators 1alpha and 1beta (PGC-1alpha and PGC-1beta) in muscle cells. J Biol Chem 278, 26597-26603, doi:10.1074/jbc.M301850200 (2003).

12 Mootha, V. K. et al. Erralpha and Gabpa/b specify PGC-1alpha-dependent oxidative phosphorylation gene expression that is altered in diabetic muscle. Proc Natl Acad Sci U S A 101, 6570-6575, doi:10.1073/pnas.0401401101 (2004).

13 Lin, J. et al. Transcriptional co-activator PGC-1a drives the formation of slow-twitch muscle fibres. Nature 418, 797-801, doi:10.1038/nature00936 (2002).

14 Calvo, J. A. et al. Muscle-specific expression of PPARgamma coactivator-1alpha improves exercise performance and increases peak oxygen uptake. J Appl Physiol (1985) 104, 1304-1312, doi:10.1152/japplphysiol.01231.2007 (2008).

15 Geng, T. et al. PGC-1alpha plays a functional role in exercise-induced mitochondrial biogenesis and angiogenesis but not fiber-type transformation in mouse skeletal muscle. Am J Physiol Cell Physiol 298, C572-579, doi:10.1152/ajpcell.00481.2009 (2010).

16 Zechner, C. et al. Total skeletal muscle PGC-1 deficiency uncouples mitochondrial derangements from fiber type determination and insulin sensitivity. Cell Metab 12, 633-642, doi:10.1016/j.cmet.2010.11.008 (2010).

17 Fan, W. et al. ERRgamma Promotes Angiogenesis, Mitochondrial Biogenesis, and Oxidative Remodeling in PGC1alpha/beta-Deficient Muscle. Cell Rep 22, 2521-2529, doi:10.1016/j.celrep.2018.02.047 (2018).

18 Olfert, I. M. et al. Muscle-specific VEGF deficiency greatly reduces exercise endurance in mice. J Physiol 587, 1755-1767, doi:10.1113/jphysiol.2008.164384 (2009).

19 Gustafsson, T., Puntschart, A., Kaijser, L., Jansson, E. & Sundberg, C. J. Exercise-induced expression of angiogenesis-related transcription and growth factors in human skeletal muscle. Am J Physiol 276, H679-685 (1999).

20 Lloyd, P. G., Prior, B. M., Yang, H. T. & Terjung, R. L. Angiogenic growth factor expression in rat skeletal muscle in response to exercise training. Am J Physiol Heart Circ Physiol 284, H1668-1678, doi:10.1152/ajpheart.00743.2002 (2003).

21 Birot, O. J., Koulmann, N., Peinnequin, A. & Bigard, X. A. Exercise-induced expression of vascular endothelial growth factor mRNA in rat skeletal muscle is dependent on fibre type. J Physiol 552, 213-221, doi:10.1113/jphysiol.2003.043026 (2003).

22 Waters, R. E., Rotevatn, S., Li, P., Annex, B. H. & Yan, Z. Voluntary running induces fiber type-specific angiogenesis in mouse skeletal muscle. Am J Physiol Cell Physiol 287, C1342-1348, doi:10.1152/ajpcell.00247.2004 (2004).

23 Bodine, S. C. et al. Akt:mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo. Nat Cell Biol 3, 1014-1019 (2001).

24 Rommel, C. et al. Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K:Akt:mTOR and PI(3)K:Akt:GSK3 pathways. Nat Cell Biol 3, 1009-1013, doi:10.1038/ncb1101-1009 (2001).

25 Mèndez, R., Myers, M. G. J., White, M. F. & Rhoads, R. E. Stimulation of Protein Synthesis, Eukaryotic Translation Initiation Factor 4E Phosphorylation, and PHAS-I Phosphorylation by Insulin Requires Insulin Receptor Substrate 1 and Phosphatidylinositol 3-Kinase. Mol Cell Biol 16, 2857-2864 (1996).

26 Welsh, G. I. et al. Activation of translation initiation factor eIF2B by insulin requires phosphatidyl inositol 3-kinase. FEBS Letters 410, 418-422, doi:10.1016/s0014-5793(97)00579-6 (1997).

27 Bodine, S. C. et al. Identification of Ubiquitin Ligases Required for Skeletal Muscle Atrophy. Science 294, 1704-1708, doi:10.1126/science.1065874 (2001).

28 Pallafacchina, G., Calabria, E., Serrano, A. L., Kalhovde, J. M. & Schiaffino, S. A protein kinase B-dependent and rapamycin-sensitive pathway controls skeletal muscle growth but not fiber type specification. Proc Natl Acad Sci U S A 99, 9213-9218, doi:10.1073/pnas.142166599 (2002).

29 Lai, K. M. et al. Conditional activation of akt in adult skeletal muscle induces rapid hypertrophy. Mol Cell Biol 24, 9295-9304, doi:10.1128/MCB.24.21.9295-9304.2004 (2004).

30 Mavalli, M. D. et al. Distinct growth hormone receptor signaling modes regulate skeletal muscle development and insulin sensitivity in mice. J Clin Invest 120, 4007-4020, doi:10.1172/JCI42447 (2010).

31 DeVol, D. L., Rotwein, P., Sadow, J. L., Novakofski, J. & Bechtel, P. J. Activation of insulin-like growth factor gene expression during work-induced skeletal muscle growth. Am J Physiol 259, E89-95 (1990).

32 Bodine, S. C. et al. Akt:mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo. Nat Cell Biol 3, 1014-1019 (2001).

33 Adams, G. R., Haddad, F. & Baldwin, K. M. Time course of changes in markers of myogenesis in overloaded rat skeletal muscles. J Appl Physiol (1985) 87, 1705-1712 (1999).

34 Miyazaki, M., McCarthy, J. J., Fedele, M. J. & Esser, K. A. Early activation of mTORC1 signalling in response to mechanical overload is independent of phosphoinositide 3-kinase/Akt signalling. J Physiol 589, 1831-1846, doi:10.1113/jphysiol.2011.205658 (2011).

35 Nader, G. A. & Esser, K. A. Intracellular signaling specificity in skeletal muscle in response to different modes of exercise. J Appl Physiol (1985) 90, 1936-1942 (2001).

36 Spangenburg, E. E., Le Roith, D., Ward, C. W. & Bodine, S. C. A functional insulin-like growth factor receptor is not necessary for load-induced skeletal muscle hypertrophy. J Physiol 586, 283-291, doi:10.1113/jphysiol.2007.141507 (2008).

37 O'Neil, T. K., Duffy, L. R., Frey, J. W. & Hornberger, T. A. The role of phosphoinositide 3-kinase and phosphatidicacid in the regulation of mammalian target of rapamycinfollowing eccentric contractions. J Physiol 587, 3691-3701 (2009).

38 Ogasawara, R. et al. The role of mTOR signalling in the regulation of skeletal muscle mass in a rodent model of resistance exercise. Sci Rep 6, 31142, doi:10.1038/srep31142 (2016).

39 Drummond, M. J. et al. Rapamycin administration in humans blocks the contraction-induced increase in skeletal muscle protein synthesis. J Physiol 587, 1535-1546, doi:10.1113/jphysiol.2008.163816 (2009).

40 Ballif, B. A. et al. Quantitative phosphorylation profiling of the ERK/p90 ribosomal S6 kinase-signaling cassette and its targets, the tuberous sclerosis tumor suppressors. Proc Natl Acad Sci U S A 102, 667-672, doi:10.1073/pnas.0409143102 (2005).

41 Ito, N., Ruegg, U. T. & Takeda, S. ATP-Induced Increase in Intracellular Calcium Levels and Subsequent Activation of mTOR as Regulators of Skeletal Muscle Hypertrophy. Int J Mol Sci 19, doi:10.3390/ijms19092804 (2018).

42 Salter, M. W. & Hicks, J. L. ATP Causes Release of Intracellular Ca*+ via the Phospholipase Cp: IP, Pathway in Astrocytes from the Dorsal Spinal Cord. J Neurosci 15, 2961-2971 (1995).

43 Kania, E., Roest, G., Vervliet, T., Parys, J. B. & Bultynck, G. IP3 Receptor-Mediated Calcium Signaling and Its Role in Autophagy in Cancer. Front Oncol 7, 140, doi:10.3389/fonc.2017.00140 (2017).

44 Ito, N., Ruegg, U. T., Kudo, A., Miyagoe-Suzuki, Y. & Takeda, S. Activation of calcium signaling through Trpv1 by nNOS and peroxynitrite as a key trigger of skeletal muscle hypertrophy. Nat Med 19, 101-106, doi:10.1038/nm.3019 (2013).

45 Bonaldo, P. & Sandri, M. Cellular and molecular mechanisms of muscle atrophy. Dis Model Mech 6, 25-39, doi:10.1242/dmm.010389 (2013).

46 Mitch, W. E. et al. Metabolic acidosis stimulates muscle protein degradation by activating the adenosine triphosphate-dependent pathway involving ubiquitin and proteasomes. J Clin Invest 93, 2127-2133, doi:10.1172/JCI117208 (1994).

47 Gomes, M. D., Lecker, S. H., Jagoe, R. T., Navon, A. & Goldberg, A. L. Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy. Proc Natl Acad Sci U S A 98, 14440-14445, doi:10.1073/pnas.251541198 (2001).

48 Cong, H., Sun, L., Liu, C. & Tien, P. Inhibition of atrogin-1/MAFbx expression by adenovirus-delivered small hairpin RNAs attenuates muscle atrophy in fasting mice. Hum Gene Ther 22, 313-324, doi:10.1089/hum.2010.057. (2011).

49 Labeit, S. et al. Modulation of muscle atrophy, fatigue and MLC phosphorylation by MuRF1 as indicated by hindlimb suspension studies on MuRF1-KO mice. J Biomed Biotechnol 2010, 693741, doi:10.1155/2010/693741 (2010).

50 Baehr, L. M., Furlow, J. D. & Bodine, S. C. Muscle sparing in muscle RING finger 1 null mice: response to synthetic glucocorticoids. J Physiol 589, 4759-4776, doi:10.1113/jphysiol.2011.212845 (2011).

51 Gomes, A. V. et al. Upregulation of proteasome activity in muscle RING finger 1-null mice following denervation. FASEB J 26, 2986-2999 (2012).

52 Lokireddy, S. et al. Myostatin induces degradation of sarcomeric proteins through a Smad3 signaling mechanism during skeletal muscle wasting. Mol Endocrinol 25, 1936-1949, doi:10.1210/me.2011-1124 (2011).

53 Lokireddy, S. et al. Identification of atrogin-1-targeted proteins during the myostatin-induced skeletal muscle wasting. Am J Physiol Cell Physiol 303, C512-529, doi:10.1152/ajpcell.00402.2011 (2012).

54 Tintignac, L. A. et al. Degradation of MyoD Mediated by the SCF (MAFbx) Ubiquitin Ligase. Journal of Biological Chemistry 280, 2847-2856, doi:10.1074/jbc.M411346200 (2005).

55 Lagirand-Cantaloube, J. et al. The initiation factor eIF3-f is a major target for Atrogin1:MAFbx function in skeletal muscle atrophy. EMBO J 27, 1266-1276, doi:10.1038/emboj.2008.52 (2008).

56 Lagirand-Cantaloube, J. et al. Inhibition of atrogin-1/MAFbx mediated MyoD proteolysis prevents skeletal muscle atrophy in vivo. PLoS One 4, e4973, doi:10.1371/journal.pone.0004973 (2009).

57 Cohen, S. et al. During muscle atrophy, thick, but not thin, filament components are degraded by MuRF1-dependent ubiquitylation. The Journal of Cell Biology 185, 1083-1095, doi:10.1083/jcb.200901052 (2009).

58 Witt, S. H., Granzier, H., Witt, C. C. & Labeit, S. MURF-1 and MURF-2 target a specific subset of myofibrillar proteins redundantly: towards understanding MURF-dependent muscle ubiquitination. J Mol Biol 350, 713-722, doi:10.1016/j.jmb.2005.05.021 (2005).

59 Sartori, R. et al. BMP signaling controls muscle mass. Nature Genetics 45, 1309-1318, doi:10.1038/ng.2772 (2013).

60 Sartori, R. et al. Smad2 and 3 transcription factors control muscle mass in adulthood. Am J Physiol Cell Physiol 296, C1248-1257, doi:10.1152/ajpcell.00104.2009 (2009).

61 Grobet, L. et al. A deletion in the bovine myostatin gene causes the double-muscled phenotype in cattle. Nat Genet 17, 71-74 (1997).

62 McPherron, A. C., Lawler, A. M. & Lee, S. J. Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member. Nature 387, 83-90, doi:10.1038/387083a0 (1997).

63 Schuelke, M. et al. Myostatin mutation associated with gross muscle hypertrophy in a child. N Engl J Med 350, 2682-2688, doi:10.1056/NEJMoa040933 (2004).

64 Clop, A. et al. A mutation creating a potential illegitimate microRNA target site in the myostatin gene affects muscularity in sheep. Nat Genet 38, 813-818, doi:10.1038/ng1810 (2006).

65 Massague, J. TGFbeta signalling in context. Nat Rev Mol Cell Biol 13, 616-630, doi:10.1038/nrm3434 (2012).

66 Goodman, C. A., McNally, R. M., Hoffmann, F. M. & Hornberger, T. A. Smad3 Induces Atrogin-1, Inhibits mTOR and Protein Synthesis, and Promotes Muscle Atrophy In Vivo. Molecular Endocrinology 27, 1946-1957, doi:10.1210/me.2013-1194 (2013).

67 Trendelenburg, A. U. et al. Myostatin reduces Akt/TORC1/p70S6K signaling, inhibiting myoblast differentiation and myotube size. Am J Physiol Cell Physiol 296, C1258-1270, doi:10.1152/ajpcell.00105.2009 (2009).

68 Massagué, J., Seoane, J. & Wotton, D. Smad transcription factors. Genes Dev 19, 2783-2810, doi:10.1101/ (2005).

69 Winbanks, C. E. et al. The bone morphogenetic protein axis is a positive regulator of skeletal muscle mass. J Cell Biol 203, 345-357, doi:10.1083/jcb.201211134 (2013).

70 Bartel, D. P. MicroRNAs- Genomics, Biogenesis, Mechanism, and Function. Cell 116, 281-297 (2004).

71 Huntzinger, E. & Izaurralde, E. Gene silencing by microRNAs: contributions of translational repression and mRNA decay. Nat Rev Genet 12, 99-110, doi:10.1038/nrg2936 (2011).

72 Kozomara, A. & Griffiths-Jones, S. miRBase: annotating high confidence microRNAs using deep sequencing data. Nucleic Acids Res 42, D68-73, doi:10.1093/nar/gkt1181 (2014).

73 Friedman, R. C., Farh, K. K., Burge, C. B. & Bartel, D. P. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res 19, 92-105, doi:10.1101/gr.082701.108 (2009).

74 Stefani, G. & Slack, F. J. Small non-coding RNAs in animal development. Nat Rev Mol Cell Biol 9, 219-230, doi:10.1038/nrm2347 (2008).

75 Hartig, S. M., Hamilton, M. P., Bader, D. A. & McGuire, S. E. The miRNA Interactome in Metabolic Homeostasis. Trends Endocrinol Metab 26, 733-745, doi:10.1016/j.tem.2015.09.006 (2015).

76 Silva, G. J. J., Bye, A., El Azzouzi, H. & Wisloff, U. MicroRNAs as Important Regulators of Exercise Adaptation. Prog Cardiovasc Dis 60, 130-151, doi:10.1016/j.pcad.2017.06.003 (2017).

77 Rupaimoole, R. & Slack, F. J. MicroRNA therapeutics: towards a new era for the management of cancer and other diseases. Nat Rev Drug Discov 16, 203-222, doi:10.1038/nrd.2016.246 (2017).

78 Wheeler, B. M. et al. The deep evolution of metazoan microRNAs. Evol Dev 11, 50-68, doi:10.1111/j.1525-142X.2008.00302.x (2009).

79 Lee, Y. et al. MicroRNA genes are transcribed by RNA polymerase II. EMBO J 23, 4051-4060, doi:10.1038/sj.emboj.7600385 (2004).

80 Lee, Y. et al. The nuclear RNase III Drosha initiates microRNA processing. Nature 425, 415-419, doi:10.1038/nature01957 (2003).

81 Yi, R. Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs. Genes & Development 17, 3011-3016, doi:10.1101/gad.1158803 (2003).

82 Lund, E., Güttinger, S., Calado, A., Dahlberg, J. E. & Kutay, U. Nuclear export of microRNA precursors. Science 303, 95-98, doi:10.1126/science.1090599 (2004).

83 Okada, C. et al. A high-resolution structure of the pre-microRNA nuclear export machinery. Science 326, 1275-1279, doi:10.1126/science.1178705 (2009).

84 Lee, Y., Jeon, K., Lee, J. T., Kim, S. & Kim, V. N. MicroRNA maturation: stepwise processing and subcellular localization. EMBO J 21, 4663-4670 (2002).

85 Kawamata, T. & Tomari, Y. Making RISC. Trends Biochem Sci 35, 368-376, doi:10.1016/j.tibs.2010.03.009 (2010).

86 Yoda, M. et al. ATP-dependent human RISC assembly pathways. Nat Struct Mol Biol 17, 17-23, doi:10.1038/nsmb.1733 (2010).

87 Khvorova, A., Reynolds, A. & Jayasena, S. D. Functional siRNAs and miRNAs Exhibit Strand Bias. Cell 115, 209-216 (2003).

88 Bartel, D. P. MicroRNAs: target recognition and regulatory functions. Cell 136, 215-233, doi:10.1016/j.cell.2009.01.002 (2009).

89 Hutvágner, G. & Zamore, P. D. A microRNA in a MultipleTurnover RNAi Enzyme Complex. Science 297, 2056-2060, doi:10.1126/science.1073827 (2002).

90 Yekta, S., Shih, I. H. & Bartel, D. P. MicroRNA-Directed Cleavage of HOXB8 mRNA. Science 304, 594-596, doi:10.1126/science.1097434 (2004).

91 Liu, Q., Wang, F. & Axtell, M. J. Analysis of complementarity requirements for plant microRNA targeting using a Nicotiana benthamiana quantitative transient assay. Plant Cell 26, 741-753, doi:10.1105/tpc.113.120972 (2014).

92 Humphreys, D. T., Westman, B. J., Martin, D. I. & Preiss, T. MicroRNAs control translation initiation by inhibiting eukaryotic initiation factor 4E/cap and poly(A) tail function. Proc Natl Acad Sci U S A 102, 16961-16966, doi:10.1073/pnas.0506482102 (2005).

93 Pillai, R. S. et al. Inhibition of translational initiation by Let-7 MicroRNA in human cells. Science 309, 1573-1576, doi:10.1126/science.1115079 (2005).

94 Mathonnet, G. et al. MicroRNA inhibition of translation initiation in vitro by targeting the cap-binding complex eIF4F. Science 317, 1764-1767, doi:10.1126/science.1146067 (2007).

95 Jonas, S. & Izaurralde, E. Towards a molecular understanding of microRNA-mediated gene silencing. Nat Rev Genet 16, 421-433, doi:10.1038/nrg3965 (2015).

96 Llave, C., Xie, Z., Kasschau, K. D. & Carrington, J. C. Cleavage of Scarecrow-like mRNA Targets Directed by a Class of Arabidopsis miRNA. Science 297, 2053-2056, doi:10.1126/science.1076311 (2002).

97 Jones-Rhoades, M. W., Bartel, D. P. & Bartel, B. MicroRNAs and Their Regulatory Roles in Plants. Annu Rev Plant Biol 57, 19-53, doi:10.1146/annurev.arplant.57.032905.105218 (2006).

98 Lewis, B. P., Burge, C. B. & Bartel, D. P. Conserved Seed Pairing, Often Flanked by Adenosines, Indicates that Thousands of Human Genes are MicroRNA Targets. Cell 120, 15-20, doi:10.1016/j.cell.2004.12.035 (2005).

99 Davis, E. et al. RNAi-mediated allelic trans-interaction at the imprinted Rtl1/Peg11 locus. Curr Biol 15, 743-749, doi:10.1016/j.cub.2005.02.060 (2005).

100 Rehwinkel, J., Behm-Ansmant, I., Gatfield, D. & Izaurralde, E. A crucial role for GW182 and the DCP1:DCP2 decapping complex in miRNA-mediated gene silencing. RNA 11, 1640-1647, doi:10.1261/rna.2191905 (2005).

101 Eulalio, A., Tritschler, F. & Izaurralde, E. The GW182 protein family in animal cells: new insights into domains required for miRNA-mediated gene silencing. RNA 15, 1433-1442, doi:10.1261/rna.1703809 (2009).

102 Braun, J. E., Huntzinger, E., Fauser, M. & Izaurralde, E. GW182 proteins directly recruit cytoplasmic deadenylase complexes to miRNA targets. Mol Cell 44, 120-133, doi:10.1016/j.molcel.2011.09.007 (2011).

103 Rouya, C. et al. Human DDX6 effects miRNA-mediated gene silencing via direct binding to CNOT1. RNA 20, 1398-1409, doi:10.1261/rna.045302.114 (2014).

104 Grimson, A. et al. MicroRNA targeting specificity in mammals: determinants beyond seed pairing. Mol Cell 27, 91-105, doi:10.1016/j.molcel.2007.06.017 (2007).

105 Chi, S. W., Zang, J. B., Mele, A. & Darnell, R. B. Argonaute HITS-CLIP decodes microRNA-mRNA interaction maps. Nature 460, 479-486, doi:10.1038/nature08170 (2009).

106 Grosswendt, S. et al. Unambiguous identification of miRNA:target site interactions by different types of ligation reactions. Mol Cell 54, 1042-1054, doi:10.1016/j.molcel.2014.03.049 (2014).

107 Agarwal, V., Bell, G. W., Nam, J. W. & Bartel, D. P. Predicting effective microRNA target sites in mammalian mRNAs. Elife 4, e05005, doi:10.7554/eLife.05005 (2015).

108 Lim, L. P. et al. Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature 433, 769-773, doi:10.1038/nature03315 (2005).

109 Han, Y. C. et al. An allelic series of miR-17 approximately 92-mutant mice uncovers functional specialization and cooperation among members of a microRNA polycistron. Nat Genet 47, 766-775, doi:10.1038/ng.3321 (2015).

110 Wang, Y., Luo, J., Zhang, H. & Lu, J. microRNAs in the Same Clusters Evolve to Coordinately Regulate Functionally Related Genes. Mol Biol Evol 33, 2232-2247, doi:10.1093/molbev/msw089 (2016).

111 Aravin, A. A. et al. The Small RNA Profile during Drosophila melanogaster Development. Developmental Cell 5, 337-350, doi:10.1016/s1534-5807(03)00228-4 (2003).

112 Altuvia, Y. et al. Clustering and conservation patterns of human microRNAs. Nucleic Acids Res 33, 2697-2706, doi:10.1093/nar/gki567 (2005).

113 Marco, A., Ninova, M., Ronshaugen, M. & Griffiths-Jones, S. Clusters of microRNAs emerge by new hairpins in existing transcripts. Nucleic Acids Res 41, 7745-7752, doi:10.1093/nar/gkt534 (2013).

114 Noguer-Dance, M. et al. The primate-specific microRNA gene cluster (C19MC) is imprinted in the placenta. Hum Mol Genet 19, 3566-3582, doi:10.1093/hmg/ddq272 (2010).

115 Inoue, K. et al. The Rodent-Specific MicroRNA Cluster within the Sfmbt2 Gene Is Imprinted and Essential for Placental Development. Cell Rep 19, 949-956, doi:10.1016/j.celrep.2017.04.018 (2017).

116 Baskerville, S. & Bartel, D. P. Microarray profiling of microRNAs reveals frequent coexpression with neighboring miRNAs and host genes. RNA 11, 241-247, doi:10.1261/rna.7240905 (2005).

117 Ryazansky, S. S., Gvozdev, V. A. & Berezikov, E. Evidence for post-transcriptional regulation of clustered microRNAs in Drosophila. BMC Genomics 12, 371, doi:10.1186/1471-2164-12-371 (2011).

118 Lagos-Quintana, M., Rauhut, R., Lendeckel, W. & Tuschl, T. Identification of novel genes coding for small expressed RNAs. Science 294, 853-858, doi:10.1126/science.1064921 (2001).

119 Chiang, H. R. et al. Mammalian microRNAs: experimental evaluation of novel and previously annotated genes. Genes Dev 24, 992-1009, doi:10.1101/gad.1884710 (2010).

120 Mukherji, S. et al. MicroRNAs can generate thresholds in target gene expression. Nat Genet 43, 854-859, doi:10.1038/ng.905 (2011).

121 Denzler, R., Agarwal, V., Stefano, J., Bartel, D. P. & Stoffel, M. Assessing the ceRNA hypothesis with quantitative measurements of miRNA and target abundance. Mol Cell 54, 766-776, doi:10.1016/j.molcel.2014.03.045 (2014).

122 Babak, T., Zhang, W., Morris, Q., Blencowe, B. J. & Hughes, T. R. Probing microRNAs with microarrays: tissue specificity and functional inference. RNA 10, 1813-1819, doi:10.1261/rna.7119904 (2004).

123 Sempere, L. F. et al. Expression profiling of mammalian microRNAs uncovers a subset of brain-expressed microRNAs with possible roles in murine and human neuronal differentiation. Genome Biol 5, R13, doi:10.1186/gb-2004-5-3-r13 (2004).

124 Zhao, Y. et al. Dysregulation of cardiogenesis, cardiac conduction, and cell cycle in mice lacking miRNA-1-2. Cell 129, 303-317, doi:10.1016/j.cell.2007.03.030 (2007).

125 Liu, N. et al. microRNA-133a regulates cardiomyocyte proliferation and suppresses smooth muscle gene expression in the heart. Genes Dev 22, 3242-3254, doi:10.1101/gad.1738708 (2008).

126 Liu, N. et al. Mice lacking microRNA 133a develop dynamin 2-dependent centronuclear myopathy. J Clin Invest 121, 3258-3268, doi:10.1172/JCI46267 (2011).

127 Heidersbach, A. et al. microRNA-1 regulates sarcomere formation and suppresses smooth muscle gene expression in the mammalian heart. Elife 2, e01323, doi:10.7554/eLife.01323 (2013).

128 Wystub, K., Besser, J., Bachmann, A., Boettger, T. & Braun, T. miR-1/133a clusters cooperatively specify the cardiomyogenic lineage by adjustment of myocardin levels during embryonic heart development. PLoS Genet 9, e1003793, doi:10.1371/journal.pgen.1003793 (2013).

129 Wei, Y. et al. Multifaceted roles of miR-1s in repressing the fetal gene program in the heart. Cell Research 24, 278-292, doi:10.1038/cr.2014.12 (2014).

130 Nie, Y. et al. Impaired exercise tolerance, mitochondrial biogenesis, and muscle fiber maintenance in miR-133a–deficient mice. The FASEB Journal 30, 3745-3758, doi:10.1096/fj.201600529R (2016).

131 Williams, A. H. et al. MicroRNA-206 delays ALS progression and promotes regeneration of neuromuscular synapses in mice. Science 326, 1549-1554, doi:10.1126/science.1181046 (2009).

132 Liu, N. et al. microRNA-206 promotes skeletal muscle regeneration and delays progression of Duchenne muscular dystrophy in mice. Journal of Clinical Investigation 122, 2054-2065, doi:10.1172/jci62656 (2012).

133 Winbanks, C. E. et al. miR-206 represses hypertrophy of myogenic cells but not muscle fibers via inhibition of HDAC4. PLoS One 8, e73589, doi:10.1371/journal.pone.0073589 (2013).

134 Boettger, T., Wüst, S., Nolte, H. & Braun, T. The miR-206:133b cluster is dispensable for development, survival and regeneration of skeletal muscle. Skelet Muscle 4, 23 (2014).

135 Anderson, C., Catoe, H. & Werner, R. MIR-206 regulates connexin43 expression during skeletal muscle development. Nucleic Acids Res 34, 5863-5871, doi:10.1093/nar/gkl743 (2006).

136 Chen, J. F. et al. The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation. Nat Genet 38, 228-233, doi:10.1038/ng1725 (2006).

137 Kim, H. K., Lee, Y. S., Sivaprasad, U., Malhotra, A. & Dutta, A. Muscle-specific microRNA miR-206 promotes muscle differentiation. J Cell Biol 174, 677-687, doi:10.1083/jcb.200603008 (2006).

138 Chen, J. F. et al. microRNA-1 and microRNA-206 regulate skeletal muscle satellite cell proliferation and differentiation by repressing Pax7. J Cell Biol 190, 867-879, doi:10.1083/jcb.200911036 (2010).

139 Goljanek-Whysall, K. et al. MicroRNA regulation of the paired-box transcription factor Pax3 confers robustness to developmental timing of myogenesis. Proc Natl Acad Sci U S A 108, 11936-11941, doi:10.1073/pnas.1105362108 (2011).

140 Zhang, D. et al. Attenuation of p38-mediated miR-1/133 expression facilitates myoblast proliferation during the early stage of muscle regeneration. PLoS One 7, e41478, doi:10.1371/journal.pone.0041478 (2012).

141 Feng, Y. et al. A feedback circuit between miR-133 and the ERK1/2 pathway involving an exquisite mechanism for regulating myoblast proliferation and differentiation. Cell Death Dis 4, e934, doi:10.1038/cddis.2013.462 (2013).

142 Koutalianos, D., Koutsoulidou, A., Mastroyiannopoulos, N. P., Furling, D. & Phylactou, L. A. MyoD transcription factor induces myogenesis by inhibiting Twist-1 through miR-206. J Cell Sci 128, 3631-3645, doi:10.1242/jcs.172288 (2015).

143 Molkentin, J. D., Black, B. L., Martin, J. F. & Olson, E. N. Cooperative activation of muscle gene expression by MEF2 and myogenic bHLH proteins. Cell 83, 1125-1136 (1995).

144 van Rooij, E. S., L.B. , Qi, X., Richardson, J. A., Hill, J. & Olson, E. N. Control of Stress-Dependent Cardiac Growth and Gene Expression by a MicroRNA. Science 316, 575-579 (2007).

145 van Rooij, E. et al. A family of microRNAs encoded by myosin genes governs myosin expression and muscle performance. Dev Cell 17, 662-673, doi:10.1016/j.devcel.2009.10.013 (2009).

146 Danzi, S., Ojamaa, K. & Klein, I. Triiodothyronine-mediated myosin heavy chain gene transcription in the heart. Am J Physiol Heart Circ Physiol 284, H2255-2262 (2003).

147 McCarthy, J. J. The MyomiR network in skeletal muscle plasticity. Exerc Sport Sci Rev 39, 150-154, doi:10.1097/JES.0b013e31821c01e1 (2011).

148 Guay, C. & Regazzi, R. Circulating microRNAs as novel biomarkers for diabetes mellitus. Nat Rev Endocrinol 9, 513-521, doi:10.1038/nrendo.2013.86 (2013).

149 Hitachi, K. & Tsuchida, K. Role of microRNAs in skeletal muscle hypertrophy. Front Physiol 4, 408, doi:10.3389/fphys.2013.00408 (2013).

150 Lee, D. E. et al. Cancer cachexia-induced muscle atrophy: evidence for alterations in microRNAs important for muscle size. Physiological Genomics 49, 253-260, doi:10.1152/physiolgenomics.00006.2017 (2017).

151 D'Souza, R. F. et al. Acute resistance exercise modulates microRNA expression profiles: Combined tissue and circulatory targeted analyses. PLoS One 12, e0181594, doi:10.1371/journal.pone.0181594 (2017).

152 Wada, S. et al. Translational suppression of atrophic regulators by microRNA-23a integrates resistance to skeletal muscle atrophy. J Biol Chem 286, 38456-38465, doi:10.1074/jbc.M111.271270 (2011).

153 Rezen, T., Kovanda, A., Eiken, O., Mekjavic, I. B. & Rogelj, B. Expression changes in human skeletal muscle miRNAs following 10 days of bed rest in young healthy males. Acta Physiol (Oxf) 210, 655-666, doi:10.1111/apha.12228 (2014).

154 Hudson, M. B. et al. miR-23a is decreased during muscle atrophy by a mechanism that includes calcineurin signaling and exosome-mediated export. Am J Physiol Cell Physiol 306, C551-558, doi:10.1152/ajpcell.00266.2013 (2014).

155 Zhang, A. et al. miRNA-23a/27a attenuates muscle atrophy and renal fibrosis through muscle-kidney crosstalk. J Cachexia Sarcopenia Muscle 9, 755-770, doi:10.1002/jcsm.12296 (2018).

156 Lin, S. T. et al. MicroRNA-23a promotes myelination in the central nervous system. Proc Natl Acad Sci U S A 110, 17468-17473, doi:10.1073/pnas.1317182110 (2013).

157 Wang, F. et al. Serum miRNAs miR-23a, 206, and 499 as Potential Biomarkers for Skeletal Muscle Atrophy. Biomed Res Int 2017, 8361237, doi:10.1155/2017/8361237 (2017).

158 Russell, A. P. et al. Disruption of skeletal muscle mitochondrial network genes and miRNAs in amyotrophic lateral sclerosis. Neurobiol Dis 49, 107-117, doi:10.1016/j.nbd.2012.08.015 (2013).

159 Vielhaber, S. et al. Mitochondrial DNA abnormalities in skeletal muscle of patients with sporadic amyotrophic lateral sclerosis. Brain 123, 1339-1348 (2000).

160 Safdar, A., Abadi, A., Akhtar, M., Hettinga, B. P. & Tarnopolsky, M. A. miRNA in the regulation of skeletal muscle adaptation to acute endurance exercise in C57Bl/6J male mice. PLoS One 4, e5610, doi:10.1371/journal.pone.0005610 (2009).

161 Russell, A. P. et al. Regulation of miRNAs in human skeletal muscle following acute endurance exercise and short-term endurance training. J Physiol 591, 4637-4653, doi:10.1113/jphysiol.2013.255695 (2013).

162 Wang, L. et al. MiR-23a inhibits myogenic differentiation through down regulation of fast myosin heavy chain isoforms. Exp Cell Res 318, 2324-2334 (2012).

163 Allen, D. L. & Loh, A. S. Posttranscriptional mechanisms involving microRNA-27a and b contribute to fast-specific and glucocorticoid-mediated myostatin expression in skeletal muscle. Am J Physiol Cell Physiol 300, C124-137, doi:10.1152/ajpcell.00142.2010 (2011).

164 Callis, T. E. et al. MicroRNA-208a is a regulator of cardiac hypertrophy and conduction in mice. J Clin Invest 119, 2772-2786, doi:10.1172/JCI36154 (2009).

165 Bell, M. L., Buvoli, M. & Leinwand, L. A. Uncoupling of expression of an intronic microRNA and its myosin host gene by exon skipping. Mol Cell Biol 30, 1937-1945, doi:10.1128/MCB.01370-09 (2010).

166 Allen, D. L. et al. Myostatin, activin receptor IIb, and follistatin-like-3 gene expression are altered in adipose tissue and skeletal muscle of obese mice. Am J Physiol Endocrinol Metab 294, E918-927, doi:10.1152/ajpendo.00798.2007 (2008).

167 Huang, Z., Chen, X., Yu, B., He, J. & Chen, D. MicroRNA-27a promotes myoblast proliferation by targeting myostatin. Biochem Biophys Res Commun 423, 265-269 (2012).

168 Sun, Y. et al. miR-24 and miR-122 Negatively Regulate the Transforming Growth Factor-β/Smad Signaling Pathway in Skeletal Muscle Fibrosis. Mol Ther Nucleic Acids 1, 528-537 (2018).

169 Wang, Q. et al. MicroRNA miR-24 inhibits erythropoiesis by targeting activin type I receptor ALK4. Blood 111, 588-595 (2008).

170 Ma, Y. et al. Functional screen reveals essential roles of miR-27a/24 in differentiation of embryonic stem cells. EMBO J 34, 361-378 (2014).

171 Li, H., Chen, J., Chen, S., Zhang, Q. & Chen, S. Antifibrotic effects of Smad4 small interfering RNAs in injured skeletal muscle after acute contusion. Int J Sports Med 32, 735-742 (2011).

172 Akimoto, T., Ribar, T. J., Williams, R. S. & Yan, Z. Skeletal muscle adaptation in response to voluntary running in Ca2+/calmodulin-dependent protein kinase IV-deficient mice. American Journal of Physiology-Cell Physiology 287, C1311-C1319, doi:10.1152/ajpcell.00248.2004 (2004).

173 Wu, H. et al. Activation of MEF2 by muscle activity is mediated through a calcineurin-dependent pathway. EMBO J 20, 6414-6423, doi:10.1093/emboj/20.22.6414 (2001).

174 Choi, S. et al. Transcriptional profiling in mouse skeletal muscle following a single bout of voluntary running: evidence of increased cell proliferation. J Appl Physiol (1985) 99, 2406-2415, doi:10.1152/japplphysiol.00545.2005 (2005).

175 Akimoto, T. et al. Exercise stimulates Pgc-1alpha transcription in skeletal muscle through activation of the p38 MAPK pathway. J Biol Chem 280, 19587-19593, doi:10.1074/jbc.M408862200 (2005).

176 Brüning, J. C. et al. A muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance. Mol Cell 2, 559-569 (1998).

177 Truett, G. E. et al. Preparation of PCR-quality mouse genomic DNA with hot sodium hydroxide and tris (HotSHOT). Biotechniques 29, 52, 54, doi:10.2144/00291bm09 (2000).

178 Nachlas, M. M., Tsou, K. C., De Souza, E., Cheng, C. S. & Seligman, A. M. Cytochemical demonstration of succinic dehydrogenase by the use of a new p-nitrophenyl substituted ditetrazole. J Histochem Cytochem 5, 420-436, doi:10.1177/5.4.420 (1957).

179 Schmidt, E. K., Clavarino, G., Ceppi, M. & Pierre, P. SUnSET, a nonradioactive method to monitor protein synthesis. Nat Methods 6, 275-277, doi:10.1038/nmeth.1314 (2009).

180 Goodman, C. A. & Hornberger, T. A. Measuring protein synthesis with SUnSET: a valid alternative to traditional techniques? Exerc Sport Sci Rev 41, 107-115, doi:10.1097/JES.0b013e3182798a95 (2013).

181 Pasut, A., Jones, A. E. & Rudnicki, M. A. Isolation and culture of individual myofibers and their satellite cells from adult skeletal muscle. J Vis Exp, e50074, doi:10.3791/50074 (2013).

182 Gallot, Y. S., Hindi, S. M., Mann, A. K. & Kumar, A. Isolation, Culture, and Staining of Single Myofibers. Bio Protoc 6, e1942, doi:10.21769/BioProtoc.1942 (2016).

183 Cabe, P. A., Tilson, H. A., Mitchell, C. L. & Dennis, R. A simple recording grip strength device. Pharmacol Biochem Behav 8, 101-102 (1978).

184 Maurissen, J. P. J., Marable, B. R., Andrus, A. K. & Stebbins, K. E. Factors affecting grip strength testing. Neurotoxicology and Teratology 25, 543-553, doi:10.1016/s0892-0362(03)00073-4 (2003).

185 Bi, P. et al. Stage-specific effects of Notch activation during skeletal myogenesis. Elife 5, e17355, doi:10.7554/eLife.17355 (2016).

186 Johnson, J. E., Wold, B. J. & Hauschka, S. D. Muscle creatine kinase sequence elements regulating skeletal and cardiac muscle expression in transgenic mice. Mol Cell Biol 9, 3393-3399 (1989).

187 Holloszy, J. O. Biochemical Adaptations in Muscle J Biol Chem 242, 2278-2282 (1967).

188 Bengtsson, J., Gustafsson, T., Widegren, U., Jansson, E. & Sundberg, C. J. Mitochondrial transcription factor A and respiratory complex IV increase in response to exercise training in humans. Pflugers Arch 443, 61-66, doi:10.1007/s004240100628 (2001).

189 Lira, V. A., Benton, C. R., Yan, Z. & Bonen, A. PGC-1alpha regulation by exercise training and its influences on muscle function and insulin sensitivity. Am J Physiol Endocrinol Metab 299, E145-161, doi:10.1152/ajpendo.00755.2009 (2010).

190 Okamoto, T., Torii, S. & Machida, S. Differential gene expression of muscle-specific ubiquitin ligase MAFbx/Atrogin-1 and MuRF1 in response to immobilization-induced atrophy of slow-twitch and fast-twitch muscles. J Physiol Sci 61, 537-546, doi:10.1007/s12576-011-0175-6 (2011).

191 Wada, S. et al. MicroRNA-23a has minimal effect on endurance exercise-induced adaptation of mouse skeletal muscle. Pflugers Arch 467, 389-398, doi:10.1007/s00424-014-1517-z (2015).

192 Tonkonogi, M. & Sahlin, K. Physical exercise and mitochondrial function in human skeletal muscle. Exerc Sport Sci Rev 30, 129-137 (2002).

193 Kim, I., Rodriguez-Enriquez, S. & Lemasters, J. J. Selective degradation of mitochondria by mitophagy. Arch Biochem Biophys 462 245-253 (2007).

194 Goh, J. & Ladiges, W. in Current Protocols in Mouse Biology Vol. 5 283-290 (Curr Protoc Mouse Biol., 2015).

195 Zhou, Q. et al. Regulation of angiogenesis and choroidal neovascularization by members of microRNA-23~27~24 clusters. Proc Natl Acad Sci U S A 108, 8287-8292, doi:10.1073/pnas.1105254108 (2011).

196 Fiedler, J. et al. MicroRNA-24 regulates vascularity after myocardial infarction. Circulation 124, 720-730, doi:10.1161/CIRCULATIONAHA.111.039008 (2011).

197 Oikawa, S., Wada, S., Lee, M., Maeda, S. & Akimoto, T. Role of endothelial microRNA-23 clusters in angiogenesis in vivo. Am J Physiol Heart Circ Physiol 315, H838-H846, doi:10.1152/ajpheart.00742.2017 (2018).

198 Mammucari, C. et al. FoxO3 controls autophagy in skeletal muscle in vivo. Cell Metab 6, 458-471 (2007).

199 Aucello, M., Dobrowolny, G. & Musarò, A. Localized accumulation of oxidative stress causes muscle atrophy through activation of an autophagic pathway. Autophagy 5, 527-529 (2009).

200 McClung, J. M., Judge, A. R., Powers, S. K. & Yan, Z. p38 MAPK links oxidative stress to autophagy-related gene expression in cachectic muscle wasting. Am J Physiol Cell Physiol 298, C542-549 (2010).

201 Paul, P. K. & Kumar, A. TRAF6 coordinates the activation of autophagy and ubiquitin-proteasome systems in atrophying skeletal muscle. Autophagy 7, 555-556 (2011).

202 Bhatnagar, S., Mittal, A., Gupta, S. K. & Kumar, A. TWEAK causes myotube atrophy through coordinated activation of ubiquitin-proteasome system, autophagy, and caspases. J Cell Physiol 227, 1042-1051 (2012).

203 Pigna, E. et al. Increasing autophagy does not affect neurogenic muscle atrophy. Eur J Transl Myol 28, 7687 (2018).

204 Quy, P. N., Kuma, A., Pierre, P. & Mizushima, N. Proteasome-dependent activation of mammalian target of rapamycin complex 1 (mTORC1) is essential for autophagy suppression and muscle remodeling following denervation. J Biol Chem 288, 1125-1134, doi:10.1074/jbc.M112.399949 (2013).

205 Lyons, G. E. et al. Developmental regulation of creatine kinase gene expression by myogenic factors in embryonic mouse and chick skeletal muscle. Development 113, 1017-1029 (1991).

206 Kelly, A. M. The Histogenesis of Rat Intercostal Muscle. The Journal of Cell Biology 42, 135-153, doi:10.1083/jcb.42.1.135 (1969).

207 Harris, A. J., Duxson, M. J., Fitzsimons, R. B. & Rieger, F. Myonuclear birthdates distinguish the origins of primary and secondary myotubes in embryonic mammalian skeletal muscles. Development 107, 771-784 (1989).

208 Hernandez-Torres, F., Aranega, A. E. & Franco, D. Identification of regulatory elements directing miR-23a-miR-27a-miR-24-2 transcriptional regulation in response to muscle hypertrophic stimuli. Biochim Biophys Acta 1839, 885-897, doi:10.1016/j.bbagrm.2014.07.009 (2014).

209 Bartel, D. P. Metazoan MicroRNAs. Cell 173, 20-51 (2018).

210 Valadi, H. et al. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 9, 654-659 (2007).